TLDR Lam Research hit an all-time high of $410.41, up 8.89% on the day The stock has returned 292% over the past year, with revenue growth of 27% Bank of AmericaTLDR Lam Research hit an all-time high of $410.41, up 8.89% on the day The stock has returned 292% over the past year, with revenue growth of 27% Bank of America

Lam Research (LRCX) Stock Hits All-Time High as BofA Lifts Target to $480

2026/06/30 00:23
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

TLDR

  • Lam Research hit an all-time high of $410.41, up 8.89% on the day
  • The stock has returned 292% over the past year, with revenue growth of 27%
  • Bank of America raised its price target to $480, maintaining a Buy rating
  • Advanced packaging revenue is expected to grow over 50% in 2026
  • InvestingPro flags the stock as currently overvalued relative to Fair Value

Lam Research (LRCX) hit an all-time high of $410.41 on Monday, with the stock up roughly 8.89% on the day and trading within 1% of its 52-week high. The company now carries a market cap of $512 billion.


LRCX Stock Card
Lam Research Corporation, LRCX

The stock has returned 292% over the past year, driven by strong revenue growth of 27% and rising demand for semiconductor equipment tied to AI infrastructure buildout.

Bank of America Securities moved first on June 23, raising its price target on LRCX from $330 to $480 while keeping its Buy rating intact. The move came after a 16% run in the stock over the prior month.

BofA updated its broader semiconductor financial model as part of the revision. The firm now expects the global semiconductor industry to hit $2.7 trillion by 2030, up from a prior estimate of $2.3 trillion.

The bullish call centers on AI-related demand for memory and advanced packaging. Lam’s management has guided for advanced packaging revenue to grow more than 50% in 2026, driven by high-bandwidth memory and 3D integration needs for AI workloads.

Analyst Price Target Upgrades

Cantor Fitzgerald has been active on the name too. The firm raised its price target to $500 from $425, pointing to market share gains in semiconductor capital equipment. An earlier Cantor note had already moved the target to $425 from $320 on AI demand and wafer fabrication equipment growth.

Mizuho also revised its target to $380 from $330. The firm cited a positive outlook for wafer fab equipment, with growth expected in AI logic and memory sectors through 2026 and 2027.

The cluster of upgrades reflects broad analyst confidence in the semiconductor equipment cycle heading into the back half of the year.

Dividend and Valuation Watch

Lam also declared a quarterly dividend of $0.26 per share, payable July 8, 2026, to shareholders on record as of June 17.

Despite the bullish momentum, InvestingPro data flags LRCX as overvalued relative to its Fair Value. The platform lists it among the most overvalued equities it tracks across more than 1,400 US stocks.

That tension — strong fundamentals, strong analyst sentiment, but stretched valuation — is something investors are watching closely.

LRCX closed Monday’s session at $409.80, up 8.89% on the day.

The post Lam Research (LRCX) Stock Hits All-Time High as BofA Lifts Target to $480 appeared first on CoinCentral.

Market Opportunity
Lorenzo Protocol Logo
Lorenzo Protocol Price(BANK)
$0.03538
$0.03538$0.03538
-0.78%
USD
Lorenzo Protocol (BANK) Live Price Chart

World Cup Combo: Aim for 200x

World Cup Combo: Aim for 200xWorld Cup Combo: Aim for 200x

Combine up to 20 World Cup matches in one order

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.